Related Experiment Video

Updated: Jun 24, 2026

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Bacterial complications during pandemic influenza infection

Tracy Hussell1, Erika Wissinger, John Goulding

  • 1National Heart & Lung Institute, Leukocyte Biology Section, Imperial College London, Exhibition Road, London, UK. t.hussell@imperial.ac.uk

Future Microbiology
|March 31, 2009
PubMed

Insights

Secondary bacterial pneumonia significantly worsens outcomes following influenza virus infection. Pandemic preparedness strategies must include judicious antibiotic use, as bacterial co-infections are a major cause of death.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pathology

Background:

  • Influenza virus infection frequently leads to secondary bacterial pneumonia, increasing mortality.
  • Historical analysis reveals high rates of bacterial lung colonization during influenza pandemics, even post-antibiotic introduction.

Discussion:

  • Bacterial pneumonia, often polymicrobial and originating from nasopharyngeal flora, is a critical factor in influenza pandemic mortality.
  • The effectiveness of antibiotics in mitigating deaths from secondary bacterial pneumonia during pandemics requires careful consideration of drug selection.

Key Insights:

  • Bacterial pneumonia is a predominant cause of death in influenza pandemics.
  • Antibiotic treatment is crucial for pandemic preparedness, but specific drug choices matter.

Outlook:

  • Future pandemic preparedness plans must integrate evidence-based antibiotic strategies to combat secondary bacterial pneumonia.
  • Further research is needed to identify optimal antibiotic regimens that minimize potential adverse effects on morbidity and mortality.

More Related Videos

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice10:47

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice

Published on: April 14, 2011

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: